Holen Sie sich die Stockscreener-App
37.33
0.16%
0.06
Handel nachbörslich:
37.63
0.30
+0.80%
Schlusskurs vom Vortag:
$37.27
Offen:
$37.06
24-Stunden-Volumen:
5,191
Relative Volume:
0.88
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.37%
1M Leistung:
-0.22%
6M Leistung:
+4.42%
1J Leistung:
+37.14%
1-Tages-Spanne:
$37.06
$37.78
1-Wochen-Bereich:
$37.02
$37.90
52-Wochen-Spanne:
$23.21
$39.37
Alps Medical Breakthroughs Etf Stock (SBIO) Company Profile
Firmenname
Alps Medical Breakthroughs Etf
Sektor
Branche
Telefon
-
Adresse
-
Alps Medical Breakthroughs Etf Aktie (SBIO) Neueste Nachrichten
Tailwinds Emerging for This Biotech ETF - ETF Trends
(SBIO) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Long Term Trading Analysis for (SBIO) - Stock Traders Daily
Why Biotech ETFs Are Beating The Market - Barchart
Why Biotech ETFs Are Beating the Market - Nasdaq
Why Biotech ETFs Are Beating the Market - Zacks Investment Research
Biotech Stocks Are Perking Up. This ETF Is Responding - ETF Trends
Financial Advocates Investment Management Purchases 385 Shares of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) - Defense World
Biotech ETF SBIO Rides Strong Momentum Into Rate Cuts - ETF Trends
Positive Biotech M&A Activity in 1H Boosts Case for Biotech ETF SBIO - ETF Trends
Learn to Evaluate (SBIO) using the Charts - Stock Traders Daily
7 Best-Performing Biotech ETFs for August 2024 - NerdWallet
Small-Cap ETFs to Rally on Upbeat U.S. Q2 GDP Growth Data? - Yahoo Finance
Small-Cap ETFs to Rally on Upbeat U.S. Q2 GDP Growth Data? - Zacks Investment Research
(SBIO) Technical Pivots with Risk Controls - Stock Traders Daily
Returns Spiking for This Rate-Sensitive ETFVettaFiCommentaries - Advisor Perspectives
Returns Spiking for This Rate-Sensitive ETF - ETF Trends
The Zacks Analyst Blog KBWR, QQQS, SVAL, EES and SBIO - Yahoo Finance
5 Small-Cap ETFs at the Forefront of the Latest Rally - Yahoo Finance
Patent Cliffs Could Spark Wave of Biotech M&A - ETF Trends
TSLA-related ETFs among top performing ETFs on a 4-week performance base last week - MSN
(SBIO) Trading Signals - Stock Traders Daily
7 Best Biotech ETFs In Canada for September 2024 - Wealth Awesome
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - MSN
How To Trade (SBIO) - Stock Traders Daily
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - TipRanks
7 Best-Performing Biotech ETFs for July 2024 - NerdWallet
4 Up-and-Coming Small-Cap Biotech Stocks to Watch - Investing.com
Tesla: Should You Buy the Stock Before Firm’s Q2 Deliveries Report? - Investing.com
4 Up-and-Coming Small-Cap Biotech Stocks to Watch - Head Topics
How to Take Advantage of moves in (SBIO) - Stock Traders Daily
S&P 500: Are You Still Waiting for a Dip That May Never Come? - Investing.com
You Can Now Access The Private Credit Market With This ETF - The Globe and Mail
Virtu Financial LLC Acquires Shares of 15725 ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) - Defense World
Best ETF Areas of Last Week - Yahoo News UK
How the (SBIO) price action is used to our Advantage - Stock Traders Daily
Big Pharma Has the Firepower for Biotech Deal-Making - ETF Trends
A Spread of ETFs to Mimic Hedge Fund Ideas - Yahoo Singapore News
New GERM ETF Launched to Tap the Growing Biotech Sector - Yahoo New Zealand News
7 Clean Energy ETFs to Buy Now | Investing | U.S. News - U.S News & World Report Money
Top Biotech Stocks 2024 - MarketBeat
Best ETF Areas of Last Week - Yahoo Lifestyle UK
Trading (SBIO) With Integrated Risk Controls - Stock Traders Daily
Biotech Wins Last Week: 5 Best ETFs - Yahoo Lifestyle Australia
Navigating The Healthcare Industry: Science Fiction Turns to Reality - Yahoo Sport Australia
Cboe Global Markets surpasses 1,000 ETFs worldwide - The Globe and Mail
ETF Issuer: Bristol Gate Capital Partners Inc. - The Globe and Mail
9 Best Biotech ETFs for 2024 - MSN
ETFs to Play Biden's 2024 Reelection Campaign Launch - Yahoo News UK
Biopharma R&D Trends Could Bode Well for This ETF - ETF Trends
5 Sector ETFs That Beat the Market in April - Yahoo Movies Canada
Finanzdaten der Alps Medical Breakthroughs Etf-Aktie (SBIO)
Es liegen keine Finanzdaten für Alps Medical Breakthroughs Etf (SBIO) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.36%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):